Director & Chief Executive Officer
Director & Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC., filing insider transactions between 2026-02-13 and 2026-03-04.
| SEC ↗ |
| 2026-03-04 | ALNY | Sale | 368 | $321.82 | $118K | SEC ↗ |
| 2026-03-04 | ALNY | Sale | 444 | $323.01 | $143K | SEC ↗ |
| 2026-03-04 | ALNY | Sale | 973 | $323.84 | $315K | SEC ↗ |
| 2026-03-04 | ALNY | Sale | 345 | $324.88 | $112K | SEC ↗ |
| 2026-03-04 | ALNY | Sale | 265 | $325.67 | $86K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 200 | $323.62 | $65K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 382 | $324.65 | $124K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 1,098 | $325.63 | $358K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 1,669 | $326.81 | $545K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 1,399 | $327.67 | $458K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 424 | $328.71 | $139K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 722 | $329.71 | $238K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 346 | $330.85 | $114K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 399 | $331.93 | $132K | SEC ↗ |
| 2026-03-02 | ALNY | Sale | 160 | $332.64 | $53K | SEC ↗ |
| 2026-02-13 | ALNY | Sale | 6,958 | $310.08 | $2.2M | SEC ↗ |